CN115708512A - Application of bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant xanthomonas diseases - Google Patents
Application of bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant xanthomonas diseases Download PDFInfo
- Publication number
- CN115708512A CN115708512A CN202211403356.0A CN202211403356A CN115708512A CN 115708512 A CN115708512 A CN 115708512A CN 202211403356 A CN202211403356 A CN 202211403356A CN 115708512 A CN115708512 A CN 115708512A
- Authority
- CN
- China
- Prior art keywords
- copper
- oxine
- tetramycin
- xanthomonas
- xanthomonas campestris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- DVWJFTGEISXVSH-CWVFEVJCSA-N (1R,3S,5S,7Z,11R,12S,13Z,15Z,17Z,19Z,21R,23S,24R,25S)-21-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-12-ethyl-1,3,5,25-tetrahydroxy-11-methyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid Chemical compound CC[C@H]1\C=C/C=C\C=C/C=C\[C@@H](C[C@@H]2O[C@@](O)(C[C@H](O)[C@H]2C(O)=O)C[C@@H](O)C[C@@H](O)C\C=C/C(=O)O[C@@H]1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N)[C@@H]1O DVWJFTGEISXVSH-CWVFEVJCSA-N 0.000 title claims abstract description 68
- 229930183279 tetramycin Natural products 0.000 title claims abstract description 68
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 54
- 201000010099 disease Diseases 0.000 title claims abstract description 53
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 40
- 241000589634 Xanthomonas Species 0.000 title claims abstract description 32
- MMUFAGXJPKNAHT-UHFFFAOYSA-N copper;quinolin-8-ol Chemical compound [Cu].C1=CN=C2C(O)=CC=CC2=C1 MMUFAGXJPKNAHT-UHFFFAOYSA-N 0.000 title claims abstract 10
- 239000004480 active ingredient Substances 0.000 claims abstract description 19
- 230000001580 bacterial effect Effects 0.000 claims description 38
- 241000196324 Embryophyta Species 0.000 claims description 37
- 239000003795 chemical substances by application Substances 0.000 claims description 37
- 241000589636 Xanthomonas campestris Species 0.000 claims description 32
- 235000014826 Mangifera indica Nutrition 0.000 claims description 27
- 235000004936 Bromus mango Nutrition 0.000 claims description 26
- 235000009184 Spondias indica Nutrition 0.000 claims description 26
- 235000020971 citrus fruits Nutrition 0.000 claims description 21
- 241000207199 Citrus Species 0.000 claims description 20
- 206010027146 Melanoderma Diseases 0.000 claims description 16
- 206010039509 Scab Diseases 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000001963 growth medium Substances 0.000 claims description 11
- 239000000375 suspending agent Substances 0.000 claims description 10
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 9
- 235000013311 vegetables Nutrition 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- 239000004562 water dispersible granule Substances 0.000 claims description 5
- 235000002566 Capsicum Nutrition 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 240000007228 Mangifera indica Species 0.000 claims description 3
- 239000002518 antifoaming agent Substances 0.000 claims description 3
- 239000002270 dispersing agent Substances 0.000 claims description 3
- 240000008574 Capsicum frutescens Species 0.000 claims description 2
- 229920000742 Cotton Polymers 0.000 claims description 2
- 239000001390 capsicum minimum Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000004530 micro-emulsion Substances 0.000 claims description 2
- 239000004563 wettable powder Substances 0.000 claims description 2
- 238000009736 wetting Methods 0.000 claims description 2
- 230000002070 germicidal effect Effects 0.000 claims 4
- 230000000855 fungicidal effect Effects 0.000 claims 3
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 45
- 230000000694 effects Effects 0.000 abstract description 15
- 230000002265 prevention Effects 0.000 abstract description 10
- 239000000575 pesticide Substances 0.000 abstract description 9
- 230000002195 synergetic effect Effects 0.000 abstract description 6
- 239000003899 bactericide agent Substances 0.000 abstract description 4
- 238000001228 spectrum Methods 0.000 abstract description 3
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 54
- 238000012360 testing method Methods 0.000 description 51
- 239000003814 drug Substances 0.000 description 28
- 241001093152 Mangifera Species 0.000 description 26
- 238000002360 preparation method Methods 0.000 description 19
- 235000013399 edible fruits Nutrition 0.000 description 17
- 230000001018 virulence Effects 0.000 description 15
- 238000007865 diluting Methods 0.000 description 13
- 239000007788 liquid Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 238000011835 investigation Methods 0.000 description 10
- 239000012452 mother liquor Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 244000052616 bacterial pathogen Species 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000000725 suspension Substances 0.000 description 8
- 241000223602 Alternaria alternata Species 0.000 description 7
- 239000010413 mother solution Substances 0.000 description 7
- 240000005561 Musa balbisiana Species 0.000 description 6
- 229920000056 polyoxyethylene ether Polymers 0.000 description 6
- 229940051841 polyoxyethylene ether Drugs 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000004721 Polyphenylene oxide Substances 0.000 description 5
- -1 alkyl naphthalene sulfonate formaldehyde Chemical compound 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- JJKSAEHNIHMQKQ-UHFFFAOYSA-N copper;quinoline Chemical compound [Cu].N1=CC=CC2=CC=CC=C21 JJKSAEHNIHMQKQ-UHFFFAOYSA-N 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000009036 growth inhibition Effects 0.000 description 5
- 229920000570 polyether Polymers 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 231100000674 Phytotoxicity Toxicity 0.000 description 4
- 241000187747 Streptomyces Species 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000017074 necrotic cell death Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- DMAXMXPDVWTIRV-UHFFFAOYSA-N 2-(2-phenylethyl)phenol Chemical compound OC1=CC=CC=C1CCC1=CC=CC=C1 DMAXMXPDVWTIRV-UHFFFAOYSA-N 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 3
- 241000588698 Erwinia Species 0.000 description 3
- 229920001732 Lignosulfonate Polymers 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- 240000000111 Saccharum officinarum Species 0.000 description 3
- 235000007201 Saccharum officinarum Nutrition 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 3
- 239000006229 carbon black Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 238000010008 shearing Methods 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 2
- 241001468265 Candidatus Phytoplasma Species 0.000 description 2
- 241000186650 Clavibacter Species 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- 241000234295 Musa Species 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 241000233679 Peronosporaceae Species 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 240000003889 Piper guineense Species 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 238000011458 pharmacological treatment Methods 0.000 description 2
- 229920005646 polycarboxylate Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229940116368 1,2-benzisothiazoline-3-one Drugs 0.000 description 1
- WFJFGMLKAISFOZ-UHFFFAOYSA-N 1-amino-3-iminourea Chemical compound NN=C(O)N=N WFJFGMLKAISFOZ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- XUJLWPFSUCHPQL-UHFFFAOYSA-N 11-methyldodecan-1-ol Chemical compound CC(C)CCCCCCCCCCO XUJLWPFSUCHPQL-UHFFFAOYSA-N 0.000 description 1
- TVFWYUWNQVRQRG-UHFFFAOYSA-N 2,3,4-tris(2-phenylethenyl)phenol Chemical compound C=1C=CC=CC=1C=CC1=C(C=CC=2C=CC=CC=2)C(O)=CC=C1C=CC1=CC=CC=C1 TVFWYUWNQVRQRG-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000566693 Asteriscus Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 229920005682 EO-PO block copolymer Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241001632576 Hyacinthus Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 241000244355 Ligusticum Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000724205 Rice stripe tenuivirus Species 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000202917 Spiroplasma Species 0.000 description 1
- 241000544993 Streptomyces ahygroscopicus Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000131694 Tenericutes Species 0.000 description 1
- 241001617088 Thanatephorus sasakii Species 0.000 description 1
- 241001494489 Thielavia Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000567083 Xanthomonas arboricola Species 0.000 description 1
- 241000589655 Xanthomonas citri Species 0.000 description 1
- 241001523965 Xylaria Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- JLOULEJYJNBUMX-UHFFFAOYSA-L copper;quinoline-2-carboxylate Chemical compound [Cu+2].C1=CC=CC2=NC(C(=O)[O-])=CC=C21.C1=CC=CC2=NC(C(=O)[O-])=CC=C21 JLOULEJYJNBUMX-UHFFFAOYSA-L 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000023753 dehiscence Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 244000037666 field crops Species 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 229940095686 granule product Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 238000010902 jet-milling Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-M naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-M 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- ZLVSYODPTJZFMK-UHFFFAOYSA-M sodium 4-hydroxybenzoate Chemical compound [Na+].OC1=CC=C(C([O-])=O)C=C1 ZLVSYODPTJZFMK-UHFFFAOYSA-M 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002723 toxicity assay Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention belongs to the field of pesticide bactericides and discloses application of a bactericidal composition containing tetramycin and oxine-copper to prevention and treatment of plant Xanthomonas diseases; the active ingredients of the bactericidal composition comprise an active ingredient A tetramycin and an active ingredient B oxine-copper. The bactericidal composition can be used for preventing and treating various diseases on plants, has good prevention and treatment effects, and has the characteristics of wide bactericidal spectrum, low dosage, obvious synergistic effect and the like.
Description
Technical Field
The invention relates to the field of pesticide bactericides, and in particular relates to application of a bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant xanthomonas diseases.
Background
Prokaryotic diseases of plants mainly occur on high-grade angiosperms, one or more bacterial diseases exist in field crops, fruit trees and vegetables, the bacterial diseases on gramineous, leguminous and solanaceous crops are more, and more than 3 bacterial diseases can occur on some crops. Plant pathogenic bacteria typically invade host plants through wounds and natural orifices (e.g., water pores, stomata, skin pores). After the plant is infected by prokaryotes, the symptoms are mainly necrosis, decay, wilting and malformation, the color change is less, and the pus is often overflowed.
Tetramycin (also called Tetramycin) is a fermentation metabolite of Streptomyces ahygroscopicus wuzhuensis subursp l1371, which has high inhibitory activity to ascomycetes, basidiomycetes and deuteromycetes. Tetramycin has systemic bacteriostatic activity and can prevent invasion and expansion of pathogenic bacteria. In addition, tetramycin not only has a strong bacteriostatic action, but also can enhance the disease resistance of plants by inducing the activity of defense enzymes to be increased.
The Copper quinolate (Copper 8-quinolate) is a chelate-state organic Copper broad-spectrum bactericide, can prevent pathogenic bacteria from contacting with crops by forming a compact protective film on the surfaces of the crops, prevents the pathogenic bacteria from infecting the crops, can also act on the interior of the pathogenic bacteria, and inhibits the activity and the conduction of main conductant of the pathogenic bacteria, thereby killing the pathogenic bacteria. The oxine-copper has prevention and treatment effects on fungal and bacterial diseases, and is suitable for preventing and treating various diseases on various crops such as fruit trees, vegetables, melons, vegetables, tobacco and the like.
The prior art CN104982446A discloses a sterilization composition containing tetramycin and oxine-copper, and discloses that the sterilization composition is used for preventing and treating sheath blight of rice and wheat, cucumber downy mildew, grape downy mildew and the like, but no relevant report exists about the application of tetramycin and oxine-copper in preventing and treating plant Xanthomonas diseases.
Disclosure of Invention
Based on the situation, the invention aims to provide the application of the bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant Xanthomonas diseases, and the bactericidal composition has a good prevention and treatment effect and has the characteristics of wide bactericidal spectrum, low dosage, obvious synergistic effect and the like.
In order to achieve the purpose, the application of the bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant Xanthomonas diseases comprises the active ingredients of A tetramycin and B oxine-copper; the mass ratio of the tetramycin to the oxine-copper is 1-1;
further, the mass ratio of the active ingredients tetramycin to the oxine-copper is 1;
further, the mass ratio of the tetramycin to the oxine-copper is 1;
further, the mass ratio of the tetramycin to the oxine-copper is 1;
further, the mass ratio of the tetramycin to the oxine-copper is 1;
furthermore, the sum of the contents of the active ingredient A and the active ingredient B in the bactericidal composition is 5-90 wt% based on the total weight of the bactericidal composition as 100wt%,
furthermore, the sum of the contents of the active ingredient A and the active ingredient B in the bactericidal composition is 10-50 wt% based on the total weight of the bactericidal composition as 100wt%,
further, the sum of the contents of the active ingredient A and the active ingredient B in the bactericidal composition is 20-50 wt% based on 100wt% of the total weight of the bactericidal composition;
furthermore, the formulation of the bactericidal composition can be any one of missible oil, aqueous emulsion, microemulsion, suspending agent, wettable powder or water dispersible granule;
further, the dosage form of the bactericidal composition is a suspending agent;
further, the suspending agent comprises, by weight, 0.01-10% of tetramycin, 1-80% of oxine-copper, and the balance of agriculturally acceptable wetting dispersant 1-20%, thickening agent 0.1-2%, antifreezing agent 1-10%, preservative 0.01-0.3%, defoaming agent 0.1-5%, and deionized water to make up to 100%;
further, the wetting agent dispersant is selected from one or more of lignosulfonate, alkyl naphthalene sulfonate formaldehyde condensate, naphthalene sulfonate, tristyrylphenol ethoxylate phosphate, fatty alcohol ethoxylate, alkylphenol polyoxyethylene ether methyl ether condensate sulfate, fatty amine polyoxyethylene ether, glycerol fatty acid ester polyoxyethylene ether, polycarboxylate, polyacrylic acid, phosphate, EO-PO block copolymer and EO-PO graft copolymer; and/or
The thickening agent is selected from one or more of xanthan gum, organic bentonite, gum arabic, sodium alginate, magnesium aluminum silicate, carboxymethyl cellulose and white carbon black; and/or
The antifreezing agent is selected from one or more of alcohols, alcohol ethers, chlorohydrocarbons and inorganic salts; and/or
The preservative is selected from one or more of propionic acid, sodium propionate, sorbic acid, sodium sorbate, potassium sorbate, benzoic acid, sodium benzoate, sodium p-hydroxybenzoate, methyl p-hydroxybenzoate, carbazone and 1, 2-benzisothiazoline 3-one; and/or
The defoaming agent is selected from C 10 -C 20 Saturated fatty acid compound, silicone oil, silicone compound, C 8 -C 10 One or more of fatty alcohols; and/or
Plant prokaryotes include the Phylum Ligusticum graciliticus, the Phylum firmicutes, the Phylum Thielavia Tenericutes; wherein the phylum of the genus Leptospira includes Agrobacterium, erwinia, pseudomonas, xanthomonas, xylaria; the phylum firmicutes include the genera Corynebacterium (Clavibacter), streptomyces (Streptomyces); thellusca comprises: spiroplasma (spiroplama), phytoplasma (Phytoplasma);
further, the plant pathogenic prokaryotes include: agrobacterium (Agrobacterium), corynebacterium (Clavibacter), erwinia (Erwinia), pseudomonas (Pseudomonas), xanthomonas (Xanthomonas), streptomyces (Streptomyces);
further, the plant diseases caused by xanthomonas include: sugarcane white stripe disease [ Xanthomonas albibililinns (Ashby) Down ], banana necrotic stripe disease [ Xanthomonas arboricola pv. Celebensis (Gaumann) Vauterin et al ], pepper leaf spot [ Xanthomonas axonodis pv. Betlicola (Patel et al.), vauterin et al ], cassava bacterial wilt disease [ Xanthomonas axonospodis pv. Manihotis (Bondar) Vauterin et al ], sugarcane gummosis [ Xanthomonas axonospodis pv. Vauterin et al ], sugarcane gummosis [ Xanthomonas axonodis pv. Vauterin et al ], mango black spot [ Xanthomonas calis. Canadensis. Orange et al ], orange mosaic virus (Brabender et al ], orange mosaic virus et al ], banana necrosis of banana necrosis stripe disease [ Xanthomonas. Albilineans (Ashbyy) Brandreamin et al ], banana necrosis of banana stripe disease [ Xanthomonas. Banana. Banana bacterial wilt [ Xanthomonas campestris pv. Musacerum (Yirgou et Bradbury) Dye ], cruciferous vegetable black rot [ Xanthomonas campestris pv. Campestis (Pammel) Dowson ], capsicum scab [ Xanthomonas campestris pv. Vesicaria ], cassava bacterial leaf spot [ Xanthomonas campestris (ex Wiehe et Dowson) Vauterin et al ], strawberry angular leaf spot [ Xanthomonas campestris from Kedy et kit ], hyacinth yellow rot [ Zanthomonas campestris (Wakker) Vauterin et al ], rice white leaf spot [ Xanthomonas campestris, oryza (Ishiyas) Swingia ] and rice stripe [ Xanthomonas campestris et al ];
further, the Xanthomonas is Xanthomonas campestris (Xanthomonas campestris);
further, the plant diseases caused by xanthomonas include: mango black spot [ Xanthomonas campestris pv. Mangifera indicae (Patel et al.), citrus canker [ Xanthomonas campestris pv. Citri (Hasse) Vauterin et al ] ], cotton bacterial angular leaf spot [ Xanthomonas campestris pv. Musacearum (Yirgou et Bradbury) Dye ], banana bacterial wilt [ Xanthomonas campestris pv. Musacearum (Yirgou et Bradbury) Dye ], brazilian vegetable black rot [ Xanthomonas campestris pv. Campestris (Pammel) Dow ], pepper scab disease [ Xanthomonas campestris pv. Campestris ];
further, the plant diseases caused by Xanthomonas campestris are mango black spot [ Xanthomonas campestris pv. Mangifera indicae (Patel et al.) Robbs et al ], citrus canker [ Xanthomonas campestris pv. Citri (Hasse) Vauterin et al ];
the bacterial alternaria alternata of the mango mainly damages leaves, branches, flowers and fruits of the mango, generates canker spots and causes fallen leaves, fallen fruits and withered branches. Polygonal or irregular black brown disease spots limited by veins appear after the leaves are infected; the branches and the spica are infected with diseases and then appear black brown ulcer spots, sometimes longitudinally crack and gummosis; after the fruit is infected, black asteriscus dehiscence spots appear, and gummosis occurs.
The citrus canker pathogen mainly harms citrus leaves, branches and fruits. The seedling and the young tree are particularly seriously damaged, so that fallen leaves and withered tips can be caused, and the tree vigor is influenced; the fruit victims fall off fruits and the light victims have scabs and are not resistant to storage and rot, so that the commodity value of the fruits is greatly reduced, the pest control cost is increased for fruit growers, and the economic benefit is damaged.
The application of a bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant Xanthomonas diseases is to apply the bactericidal composition to the diseases to be controlled or a growth medium thereof in an effective dose;
further, the effective dose of the bactericidal composition is 147-189g.ai/hm 2 。
Compared with the prior art, the technical scheme of the invention has the following beneficial effects:
1) The tetramycin and the oxine-copper are compounded, so that the bactericidal activity is increased, and the xanthomonas disease can be effectively prevented and treated;
2) The method is safe and environment-friendly, has wide development prospect, reduces the usage amount of pesticides and reduces the agricultural cost;
3) The bactericidal composition has super-high efficiency and wide bactericidal spectrum, and can delay the generation of the drug resistance of harmful bacteria and prolong the drug duration.
Detailed Description
To make the technical solutions, objects, and advantages of the present invention more apparent, the present invention is described with the following specific examples, but the present invention may be implemented in various forms and should not be limited by the embodiments set forth herein.
Indoor toxicity assay
Examples reference indoor bioassay test guidelines for pesticides, part 16: a turbidity method for a bacterial growth inhibition test, NY/T1156.16-2008; section 6: combined effect of compounding determined NY/T1156.6-2006.
Example 1
Virulence determination of tetramycin and oxine-copper on mango bacterial black spot
Pathogenic bacteria to be tested: mango bacterial black spot (Xanthomonas campestris pv. Mangiferaeindica) was supplied by the group research and development center.
Reagent to be tested: 15% of tetramycin parent drug and 98% of oxine-copper original drug, wherein the original drugs are provided by group research and development centers.
Inoculating the mango bacterial alternaria alternata to a nutrient agar culture medium (NA), and placing the mango bacterial alternaria alternata in a constant-temperature illumination incubator at 28 ℃ for continuous dark culture for 24 hours. Then inoculating the mango bacterial alternaria alternata grown on the NA culture medium to an NB culture medium for shake culture for 12h, diluting with sterile water to 1 × 10 7 Spore suspension at individual spores/mL concentration, ready for use.
Preparing a medicament mother solution: preparing tetramycin and oxine-copper into 1 × 10 4 mg/L mother liquor; mixing tetramycin and oxine-copper according to the following proportion: oxine-copper =1, 30, 1 4 mixing the mother liquor at mg/L for later use.
Dose setting: each single agent and different proportions are mixed and mixed according to the content of effective components, and 5 series of mass concentration treatments are respectively set, and the specific treatment dosage is as follows:
tetramycin (a): 2.1, 0.5, 0.25, 0.125mg/L;
oxine-copper (B): 320. 160, 80, 40, 20mg/L;
A:B(1:1)：4、2、1、0.5、0.25mg/L；
A:B(1:30)：40、20、10、5、2.5mg/L；
A:B(1:49)：40、20、10、5、2.5mg/L；
A:B(1:55)：40、20、10、5、2.5mg/L；
A:B(1:60)：40、20、10、5、2.5mg/L；
A:B(1:65)：40、20、10、5、2.5mg/L；
A:B(1:70)：60、30、15、7.5、3.75mg/L；
A:B(1:75)：60、30、15、7.5、3.75mg/L；
A:B(1:89)：80、40、20、10、5mg/L；
A:B(1:100)：100、50、25、12.5、6.25mg/L；
preparing a medicament: diluting tetramycin mother liquor to 20, 10, 5, 2.5 and 1.25mg/L; diluting the oxine-copper mother liquor to 3200, 1600, 800, 400 and 200mg/L; diluting a mother solution mixed by tetramycin and oxine-copper according to the proportion of 1; diluting a mother solution prepared by mixing tetramycin and oxine-copper according to the following mixture ratio of 1; diluting a mother solution mixed by tetramycin and oxine-copper according to the mixture ratio of 1; diluting a mother solution mixed by tetramycin and oxine-copper according to the proportion of 1; and (3) diluting the mother liquor mixed by tetramycin and oxine-copper according to the mixture ratio of 1.
The test agent was treated in 4 flasks per concentration, one flask per replicate, for 4 replicates, with an aqueous solution without agent as a blank.
And (3) inoculating activated and cultured mango bacterial alternaria alternata for 24 hours on an NA culture medium, and performing medicament treatment according to the dose setting.
Under aseptic conditions, each treatment drug prepared at a concentration 10 times the design concentration was quantitatively aspirated from a low concentration to a high concentration in a previously sterilized 100mL Erlenmeyer flask containing 45mL of NB culture medium5mL of the solution was added to each flask and shaken well. The experiment was set to add an aqueous solution without agent as a blank, with 4 replicates per treatment. Then preparing in advance to have a concentration of 1X 10 7 Inoculating mango bacterial alternaria alternata bacterial liquid with each spore/mL concentration into a triangular flask, inoculating 100ul of the bacterial liquid into each flask, fully and uniformly mixing, respectively taking 10mL of the bacterial liquid out for each treatment, placing the tubes into the test tubes for standby, sealing the triangular flasks, and placing the tubes at 28 ℃ for continuous shaking culture (120 r/min).
Investigation method, time, number of times: respectively measuring 10ml of mixed liquid taken out from each treatment, and recording the turbidity of each treatment; after a certain period of incubation, the turbidity of each treatment was measured and recorded when the control treatment reached exponential growth phase.
Data processing: according to the investigation result, the bacterial growth inhibition rate of each treatment concentration on the test target is calculated according to the formulas (1) and (2).
Calculating the experiment result by adopting IBM SPSS statics 20 data processing software, and respectively calculating the toxicity regression equation and EC of 2 single agents and 5 mixture ratio combinations of the test medicament 50 And 95% confidence limits and R 2 。
A＝A 1 -A 2······ (1)
In the formula:
a represents the turbidity increase value of the bacterial liquid;
A 1 represents the turbidity of the bacterial liquid after culture;
A 2 the turbidity of the culture broth before the culture was expressed.
P＝[(A 0 -At)/A 0 ]×100······(2)
In the formula:
p represents a growth inhibition rate;
A 0 indicates the blank control turbidity increase value;
at represents the increase in turbidity of the pharmacological treatment.
Calculating co-toxicity coefficient (CTC) according to Sun Yunpei method, and evaluating synergistic effect of the mixed medicines according to the co-toxicity coefficient (CTC), i.e. the antagonism is achieved when CTC is less than or equal to 80, the additivity is achieved when CTC is more than 80 and less than 120, and the synergy is achieved when CTC is more than or equal to 120.
The co-toxicity coefficient (CTC) is calculated according to the formulas (3), (4) and (5).
TI＝(S/T)×100······(3)
In the formula:
TI represents the actually measured virulence index of the test agent;
s represents EC for standard pharmaceutical agent 50 (mg/L)；
T represents EC of test agent 50 (mg/L)。
TTI＝TI A ×P A +TI B ×P B······ (4)
In the formula:
TTI represents the theoretical virulence index of the mixture;
TI A represents the virulence index of agent a;
P A the percentage (%) of the agent A in the mixture is shown;
TI B represents the virulence index of agent B;
P B the percentage (%) of the agent B in the mixture is shown.
CTC＝(ATI/TTI)×100······(5)
In the formula:
CTC represents co-toxicity coefficient;
ATI represents the actually measured virulence index of the mixed preparation;
TTI represents the theoretical virulence index of the mixture.
Results and analysis:
as can be seen from table 1: the tetramycin and oxine-copper single agent and the compound medicament thereof have better bactericidal activity on mango bacterial alternaria alternata, and the tetramycin single agent EC 50 The value is 0.402mg/L, quinoline copper single dose EC 50 The value was 71.536mg/L.
The mass ratio of the tetramycin to the oxine-copper is 1-1, and the antagonism is not shown in the range of 100, the mass ratio of 1 50 13.973mg/L, a co-toxicity coefficient of 146.598 and obvious synergistic effect.
TABLE 1 indoor combined virulence results for mango bacterial black spot for different ratios of tetramycin and oxine-copper
Example 2
Toxicity determination of tetramycin and oxine-copper on citrus canker
Pathogenic bacteria to be tested: citrus canker pathogen (Xanthomonas campestris pv. Citri), supplied by the research and development center of the group.
Reagent to be tested: 15% of tetramycin mother drug and 98% of oxine-copper raw drug, which are provided by group research and development centers.
Inoculating the citrus canker into nutrient agar culture medium (NA), and continuously culturing in dark for 24h in a constant-temperature illumination incubator at 28 ℃. Inoculating Citrus canker grown on NA culture medium to NB culture medium, shake culturing for 12 hr, diluting with sterile water to 1 × 10 7 Spore suspension at individual spore/ml concentration, ready for use.
Preparing a medicament mother solution: preparing tetramycin and oxine-copper into 1 × 10 4 mg/L mother liquor; mixing tetramycin and oxine-copper according to the following proportion: oxine-copper =1, 49, 59, 1, 69, 1, 79, 1 4 mixing the mother liquor at mg/L for later use.
Dose setting: each single agent and different proportions are mixed and mixed according to the content of effective components, and 5 series of mass concentration treatments are respectively set, and the specific treatment dosage is as follows:
tetramycin (a): 2.1, 0.5, 0.25, 0.125mg/L;
oxine-copper (B): 320. 160, 80, 40, 20mg/L;
A:B(1:49)：60、30、15、7.5、3.75mg/L；
A:B(1:59)：60、30、15、7.5、3.75mg/L；
A:B(1:69)：80、40、20、10、5mg/L；
A:B(1:79)：80、40、20、10、5mg/L；
A:B(1:89)：80、40、20、10、5mg/L；
preparing a medicament: diluting tetramycin mother liquor to 20, 10, 5, 2.5 and 1.25mg/L; diluting the oxine-copper mother liquor to 3200, 1600, 800, 400 and 200mg/L; diluting a mother solution mixed by tetramycin and oxine-copper according to the mixture ratio of 1; and (2) diluting the mother liquor obtained by mixing tetramycin and oxine-copper according to the mixture ratio of 1.
Test agents 4 flasks were treated per concentration, one flask for each replicate for 4 replicates, with an aqueous solution without agent as a blank.
And (3) transferring activated citrus canker germs on an NA culture medium and culturing for 24 hours, and performing medicament treatment according to the dose setting.
Under aseptic conditions, 5mL of each treatment solution prepared at a concentration 10 times the designed concentration was quantitatively aspirated from a previously sterilized 100mL Erlenmeyer flask containing 45mL of NB culture medium in the order of low concentration to high concentration, and each solution was added to the Erlenmeyer flask and shaken well. The experiment was set to add an aqueous solution without agent as a blank, with 4 replicates per treatment. Then preparing in advance at a concentration of 1 × 10 7 Inoculating bacterial liquid of citrus canker pathogen with spore/mL concentration into triangular flasks, inoculating 100ul bacterial liquid into each flask, mixing well, taking 10mL of bacterial liquid out of each treatment respectively for standby, sealing the triangular flasks, and continuously shaking and culturing at 28 ℃ (120 r/min).
Investigation method, time, number of times: respectively measuring 10mL of mixed liquid taken out from each treatment, and recording the turbidity of each treatment; after a certain period of incubation, the turbidity of each treatment was measured and recorded when the control treatment reached exponential growth phase.
Data processing: according to the investigation result, the bacterial growth inhibition rate of each treatment concentration on the test target is calculated according to the formulas (1) and (2). Calculating the experiment result by adopting IBM SPSS statics 20 data processing software, and respectively calculating the toxicity regression equation and EC of 2 single agents and 5 mixture ratio combinations of the test medicament 50 And 95%Confidence limits and R 2 。
A＝A 1 -A 2 ······(1)
In the formula:
a represents the turbidity increase value of the bacterial liquid;
A 1 represents the turbidity of the bacterial liquid after culture;
A 2 the turbidity of the culture broth before the culture was expressed.
P＝[(A 0 -At)/A 0 ]×100······(2)
In the formula:
p represents growth inhibition rate;
A 0 represents the blank control turbidity increase;
at represents the increase in turbidity of the pharmacological treatment.
Calculating co-toxicity coefficient (CTC) according to Sun Yunpei method, and evaluating synergistic effect of the mixed medicines according to the co-toxicity coefficient (CTC), i.e. the antagonism is achieved when CTC is less than or equal to 80, the additivity is achieved when CTC is more than 80 and less than 120, and the synergy is achieved when CTC is more than or equal to 120.
The co-toxicity coefficient (CTC) is calculated according to the formulas (3), (4) and (5).
TI＝(S/T)×100······(3)
In the formula:
TI represents the actually measured virulence index of the test agent;
s represents EC for standard medicament 50 (mg/L)；
T represents EC of test agent 50 (mg/L)。
TTI＝TI A ×P A +TI B ×P B ······(4)
In the formula:
TTI represents the theoretical virulence index of the compound;
TI A represents the virulence index of agent a;
P A the percentage (%) of the agent A in the mixture is shown;
TI B represents the virulence index of agent B;
P B the percentage (%) of the agent B in the mixture is shown.
CTC＝(ATI/TTI)×100······(5)
In the formula:
CTC represents co-toxicity coefficient;
ATI represents the actually measured virulence index of the mixed preparation;
TTI represents the theoretical virulence index of the cocktail.
Results and analysis:
as can be seen from table 2: the tetramycin and oxine-copper single agent and the compound medicament thereof have better bactericidal activity on citrus canker, and the tetramycin single agent EC 50 The value is 0.485mg/L, quinoline copper single dose EC 50 The value was 79.886mg/L.
The mass ratio of the tetramycin to the oxine-copper is 1-49 50 17.485mg/L, the co-toxicity coefficient is 136.842, and the synergistic effect is obvious.
TABLE 2 indoor combined virulence results of tetramycin and oxine-copper in different ratios for citrus canker pathogens
The specific preparation example is as follows:
preparation example 1:35wt% Tetramycin-copper quinolate suspension (1
The formula is as follows: tetramycin 0.5%, oxine-copper 34.5%, polyether 3%, phenethyl phenol polyether phosphate salt 2.5%, guerbet alcohol polyoxyethylene ether (xp-70) 2%, magnesium aluminum silicate 0.9%, xanthan gum 0.1%, propylene glycol 3%, glycerol 1%, benzisothiazolinone 0.02%, dimethyl silicone oil 0.4%, and deionized water for complement;
the preparation method comprises the following steps: tetramycin and additives (except preservatives and thickening agents) are added into a feeding kettle, and shearing is started to completely dissolve the additives. And adding oxine-copper under high-shear stirring, uniformly shearing, sanding, transferring to a homogenizing kettle after sanding, adding a preservative and a thickening agent, adding the rest water to complement the balance, shearing, and homogenizing and mixing to obtain a corresponding product.
Preparation example 2:36wt% Tetramycin-oxine-copper suspension (1
The formula is as follows: 0.8% tetramycin, 35.2% oxine-copper, 3% polyether, 3.5% phenethyl phenol polyether phosphate, 1.2% Guerbet alcohol polyoxyethylene ether, 0.8% magnesium aluminum silicate, 0.2% xanthan gum, 5% propylene glycol, 0.02% benzisothiazolinone, 0.35% dimethyl silicone oil, deionized water to complement
The preparation method comprises the following steps: the same as in preparation example 1.
Preparation example 3:42.6wt% Tetramycin-Quinoline copper suspension (1
The formula is as follows: 0.6% of tetramycin, 42% of oxine-copper, 0.5% of alkyl sulfonate, 0.5% of polycarboxylate, 3% of phenethyl phenol polyether phosphate, 2% of isotridecyl alcohol polyoxyethylene ether, 1% of magnesium aluminum silicate, 0.2% of xanthan gum, 5% of propylene glycol, 0.1% of benzoic acid, 0.35% of simethicone and the balance of deionized water;
the preparation method comprises the following steps: the same as in preparation example 1.
Preparation example 4:33wt% tetramycin quinoline copper water dispersible granule (1
The formula is as follows: tetramycin 0.5%, oxine-copper 32.5%, lignosulfonate 5%, sodium dodecyl benzene sulfonate 7.5%, aluminum chloride 8% and white carbon black for supplement.
The preparation method comprises the following steps: according to the formula proportion of the embodiment, the active ingredients of tetramycin and oxine-copper are added into a carrier, a surfactant and other functional auxiliaries are added into the carrier, the carrier and the carrier are mixed, 10-25% of water is added after the mixture is subjected to jet milling, and then the water dispersible granule product is prepared through kneading, granulating, drying and screening.
Preparation example 5:40wt% tetramycin quinoline copper water dispersible granule (1
The formula is as follows: tetramycin 1%, oxine-copper 39%, lignosulfonate 5%, sodium dodecyl benzene sulfonate 7.5%, aluminum chloride 4%, bentonite 10% and white carbon black for supplement.
The preparation method comprises the following steps: the same as in preparation example 4.
Example 3
Prevention and control of mango bacterial black spot by field test
Test article: mango;
test subjects: bacterial black spot;
test reagents: 35% tetramycin-oxine-copper suspension;
control agents: 40% of a copper quinoline suspending agent and 0.3% of a tetramycin aqueous agent;
medicament treatment and dosage:
TABLE 3 test design of test agents
The test is carried out in mango planting bases in Guangzhou city, open field cultivation, fertilizer and water management, and moderate soil fertility. The growth vigor is good, and no bactericide is sprayed from the plant permanent planting to the first pesticide application period.
The bacterial black spot in the test field is seriously damaged, and the conditions of soil, cultivation, water and fertilizer management and the like in each test area are consistent.
And (3) test treatment: each treatment adopts random block arrangement, buffer lines are arranged between adjacent cells, and the treatment is repeated for 4 times, and the mango trees are 3.
The application time is as follows: the medicine is applied in the young shoot stage, namely, the medicine is applied twice in 4-month and 18-day and 4-month and 28-day respectively in 2020. The daily maximum temperature during the test was 31 ℃ and the minimum temperature was 14 ℃.
Investigation time: mango disease was investigated each time the disease was stable in the placebo plot at 23 days 5/2020.
The investigation method comprises the following steps: only individual leaves were visible as bacterial black spot lesions at the beginning of the trial, so the disease base was not investigated. During test investigation, two plants are investigated in each cell, each plant is sampled according to five points of east, west, south, north and middle, all the leaves of 2 tips are investigated at each point, and the total leaf number and the diseased leaf number at each level are recorded and investigated.
The leaf grading method comprises the following steps:
stage 0: no disease;
level 1: each leaf has 1 to 5 scabs;
and 3, level: each leaf has 6 to 10 scabs;
stage 5: each leaf has 11 to 15 scabs;
and 7, stage: each leaf has 16 to 20 scabs;
and 9, stage: each leaf has more than 21 scabs.
Investigation time and number of times: the disease condition base is investigated before the application of the medicine, and the prevention and treatment effect is investigated 25 days after the last application of the medicine.
The drug effect calculation method comprises the following steps:
disease index = disease index (%) = [ Σ (number of diseased plants at each level × relative level value)/(number of total investigated plants × 9) ] × 100
Control effect (%) = [ (control area disease index-treatment area disease index)/control area disease index ] × 100
During the test period, the mangoes in all treatment cells are observed to grow well, and no phytotoxicity occurs in all treatments.
The test results of each treatment agent for controlling mango bacterial black spot are shown in the following table:
TABLE 4 field test results of different tested agents on mango bacterial black spot
Note: the control (%) in the table above is the average of each repetition. Lower case letters represent 5% level difference and upper case letters represent 1% level difference.
The results show that: the test agent 35% tetramycin-oxine-copper suspending agent has good prevention and treatment effects on mango bacterial black spot, and the prevention effects of the three treatments are 90.48%, 90.98% and 92.17% respectively.
The test agent 35% tetramycin-oxine-copper suspending agent has no phytotoxicity on mango after being treated, and no other influence of the test agent on test plants is found in the application observation period.
Example 4
Prevention and control of citrus canker by field test
And (3) standard: field efficacy test criteria (second) section 103: GB/T17980.103-2004 test crops for preventing and treating citrus canker: citrus fruit
Test subjects: ulcer disease
Test site: guangxi Guilin
Experiment time: the administration was performed twice on 12 days in month 4 and 26 days in month 4 in 2020. Sporadic ulcerations were visible on the leaves at the beginning of the test. The weather is good during the test period, and the daily maximum temperature is 26 ℃ and the daily minimum temperature is 8 ℃ during the test period.
Test site: the soil fertility of the test field is medium, the terrain is smooth, the fertility is uniform, and the irrigation condition is good. All test plot cultivation conditions (soil type, fertilization, cultivation, row spacing, etc.) were uniform and consistent with local agricultural cultivation practices (GAP).
And (3) test treatment: each treatment adopts random block arrangement, buffer lines are arranged between adjacent cells, and the process is repeated for 4 times, wherein each cell contains 3 citrus trees.
The investigation method comprises the following steps: two plants were investigated per plot, each plant was sampled at five points in the east, west, south and north, and 10 fruits and all leaves on both shoots were investigated per point.
Leaf (fruit) grading method:
stage 0: no disease exists;
level 1: each leaf (fruit) has 1-5 scabs;
and 3, level: each leaf (fruit) has 6-10 scabs;
and 5, stage: each leaf (fruit) has 11 to 15 scabs;
and 7, stage: each leaf (fruit) has 16 to 20 scabs;
and 9, stage: each leaf (fruit) has more than 21 scabs.
Investigation time and number of times: the disease condition base is investigated before the application of the medicine, and the prevention and treatment effect is investigated 20 days after the last application of the medicine.
The drug effect calculation method comprises the following steps:
disease index = disease index (%) = [ Σ (number of diseased plants at each stage × relative stage value)/(total number of investigated plants × 9) ] × 100
Control effect (%) = [ (control area disease index-treatment area disease index)/control area disease index ] × 100
During the test period, the growth of the citrus in each treatment cell is observed to be good, and no phytotoxicity is generated in each treatment.
The test results of the treatment medicaments for preventing and treating the citrus canker disease are as follows:
TABLE 5 field test results of different test reagents for citrus canker
Note: the control (%) in the table above is the average of each repetition. Lower case letters represent 5% level difference and upper case letters represent 1% level difference.
The results show that: the reagent 35% tetramycin and oxine-copper suspending agent has good control effect on mango bacterial black spot, and the control effects of the three treatments are 90.13%, 90.65% and 92.94% respectively.
Example 5
35% tetramycin-oxine-copper suspension (0.5% + 34.5%) for preventing and controlling plant xanthomonas diseases
And (3) field test results:
TABLE 6 field test results for 35% tetramycin-oxine-copper suspension (0.5% + 34.5%) control of plant Xanthomonas diseases
Through indoor toxicity measurement and field tests, the pesticide composition compounded by tetramycin and oxine-copper has a good control effect on plant xanthomonas diseases.
The pesticide composition or the preparation thereof obtained by compounding has obvious control effect, and is superior to a single preparation in the aspects of delaying the generation of drug resistance and prolonging the lasting period. And no phytotoxicity of the compound pesticide on crops is found in tests, which shows that the production cost and the use cost can be reduced and the pesticide composition or the preparation is safe to the crops under the condition of improved sterilization synergy.
Although the invention has been described in detail with respect to the general description and the specific embodiments thereof, it will be apparent to those skilled in the art that modifications and improvements can be made thereto without departing from the spirit of the invention.
Claims (10)
1. The application of the bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant Xanthomonas diseases is characterized in that: the active ingredients of the sterilization composition comprise an active ingredient A tetramycin and an active ingredient B oxine-copper, wherein the mass ratio of the tetramycin to the oxine-copper is (1-1).
2. The germicidal composition as claimed in claim 1, wherein: the mass ratio of the active component tetramycin to the oxine-copper is (1);
preferably, the mass ratio of the active ingredient tetramycin to the oxine-copper is 1;
more preferably, the mass ratio of the active ingredients tetramycin to the oxine-copper is 1.
3. The germicidal composition as claimed in claim 1, wherein: the sum of the contents of the active ingredient A and the active ingredient B in the bactericidal composition is 5-90 wt%, preferably 10-50 wt%, and more preferably 20-50 wt%, based on the total weight of the bactericidal composition being 100 wt%.
4. The germicidal composition of claim 1, wherein: the formulation of the bactericidal composition can be any one of missible oil, aqueous emulsion, microemulsion, suspending agent, wettable powder or water dispersible granules;
preferably, the dosage form of the bactericidal composition is a suspending agent.
5. The germicidal composition of claim 4, wherein: the suspending agent comprises, by weight, 0.01-10% of tetramycin, 1-80% of oxine-copper, and the balance of agriculturally acceptable wetting dispersant 1-20%, thickening agent 0.1-2%, antifreezing agent 1-10%, preservative 0.01-0.3%, defoaming agent 0.1-5%, and deionized water to make up to 100%.
6. Use of the fungicidal composition according to claim 1 for controlling plant xanthomonas diseases, characterized in that: the plant Xanthomonas is Xanthomonas campestris (Xanthomonas campestris).
7. Use of the fungicidal composition according to claim 6 for controlling plant Xanthomonas diseases, characterized in that: the plant Xanthomonas disease is a plant disease caused by Xanthomonas campestris; preferably, the plant diseases caused by Xanthomonas campestris include: mango black spot [ Xanthomonas campestris pv. Mangiferae et al ], citrus canker [ Xanthomonas campestris pv. Citri (Hasse) Vauterin et al ], cotton bacterial angular leaf spot [ Xanthomonas campestris pv. Musacerurum (Yirgou et Bradbury) Dye ], banana bacterial wilt [ Xanthomonas campestris pv. Musacerurum (Yirgou et dbury) Dye ], cruciferous vegetable black rot [ Xanthomonas campestris pv. Campestis. Pammus) Dowson ], capsicum scab [ Xanthomonas campestris pv. Simplex.
8. The use of the fungicidal composition according to claim 7 for controlling xanthomonas diseases in plants, characterized in that: the plant diseases caused by Xanthomonas campestris are mango black spot [ Xanthomonas campestris pv. Mangiferaeindica (Patel et al.) Robbs et al ], citrus canker [ Xanthomonas campestris pv. Citri (Hasse) Vauterin et al ].
9. The bactericidal composition of claim 1, wherein the bactericidal composition is applied to the disease or growth medium thereof to be controlled in an effective amount.
10. The bactericidal composition of claim 9, wherein the effective amount of the bactericidal composition is 147-189g.a i/hm 2 。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111668890X | 2021-12-31 | ||
| CN202111668890.XA CN114190395A (en) | 2021-12-31 | 2021-12-31 | Application of bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant xanthomonas diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115708512A true CN115708512A (en) | 2023-02-24 |
Family
ID=80657729
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111668890.XA Pending CN114190395A (en) | 2021-12-31 | 2021-12-31 | Application of bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant xanthomonas diseases |
| CN202211403356.0A Pending CN115708512A (en) | 2021-12-31 | 2022-11-10 | Application of bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant xanthomonas diseases |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111668890.XA Pending CN114190395A (en) | 2021-12-31 | 2021-12-31 | Application of bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant xanthomonas diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN114190395A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115058471A (en) * | 2022-07-04 | 2022-09-16 | 辽宁微科生物工程有限公司 | Method for preparing tetramycin medical fertilizer by using streptomyces hygroscopicus and application of tetramycin medical fertilizer |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102498963A (en) * | 2011-11-15 | 2012-06-20 | 仲恺农业工程学院 | Method for preventing and treating bacterial leaf spot of poinsettia |
| CN104604895A (en) * | 2013-11-26 | 2015-05-13 | 辽宁微科生物工程有限公司 | Tetramycin compound and application |
| CN104982446A (en) * | 2015-07-25 | 2015-10-21 | 海利尔药业集团股份有限公司 | Bactericidal composition containing tetramycin and copper quinolate |
| CN110800754A (en) * | 2019-11-18 | 2020-02-18 | 扬州大学 | Compound preparation for preventing and treating peach bacterial perforation disease and application |
-
2021
- 2021-12-31 CN CN202111668890.XA patent/CN114190395A/en active Pending
-
2022
- 2022-11-10 CN CN202211403356.0A patent/CN115708512A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102498963A (en) * | 2011-11-15 | 2012-06-20 | 仲恺农业工程学院 | Method for preventing and treating bacterial leaf spot of poinsettia |
| CN104604895A (en) * | 2013-11-26 | 2015-05-13 | 辽宁微科生物工程有限公司 | Tetramycin compound and application |
| CN104982446A (en) * | 2015-07-25 | 2015-10-21 | 海利尔药业集团股份有限公司 | Bactericidal composition containing tetramycin and copper quinolate |
| CN110800754A (en) * | 2019-11-18 | 2020-02-18 | 扬州大学 | Compound preparation for preventing and treating peach bacterial perforation disease and application |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115058471A (en) * | 2022-07-04 | 2022-09-16 | 辽宁微科生物工程有限公司 | Method for preparing tetramycin medical fertilizer by using streptomyces hygroscopicus and application of tetramycin medical fertilizer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114190395A (en) | 2022-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105961399B (en) | Bactericidal composition and its application | |
| CN114052035B (en) | Insecticidal composition containing emamectin benzoate B2a benzoate | |
| CN110558332A (en) | Synergistic bactericidal composition containing bacillus amyloliquefaciens B1126 and application thereof | |
| CN115708512A (en) | Application of bactericidal composition containing tetramycin and oxine-copper in preventing and treating plant xanthomonas diseases | |
| CN103749542B (en) | Bacillusamyloliquefaciens and validamycin compound biological bactericide and application thereof | |
| CN114617129B (en) | Sterilization composition and application thereof | |
| CN114916553A (en) | Bactericidal composition for wheat scab and corn northern leaf blight | |
| CN117546850A (en) | Nematicidal composition containing cyclopurifiuram and application thereof | |
| CN108184864B (en) | Compound composition containing oxathiapiprolin and osthole and application thereof | |
| CN114041473A (en) | Bactericidal composition containing metconazole and pyraclostrobin and application thereof | |
| CN108378055B (en) | Pesticide composition containing pyraclostrobin, pesticide and application | |
| CN110800750A (en) | Pesticide bactericidal composition and preparation thereof | |
| CN114766492B (en) | Pesticide composition containing bixafen and application thereof | |
| CN114617128B (en) | Pesticide composition containing copper quinolinate and application thereof | |
| CN115104621B (en) | Sterilization composition containing fosetyl-aluminum and application thereof | |
| CN114391545B (en) | Pesticide composition containing bixafen and copper quinolinate and application thereof | |
| CN114451416B (en) | Pesticide composition containing benzovindiflupyr and application thereof | |
| CN114766493B (en) | Sterilization composition containing agricultural antibiotics and application thereof | |
| CN114938808B (en) | Magnolol and nuciferine pharmaceutical composition and preparation method thereof | |
| CN115918656B (en) | Bactericidal composition containing biological extract | |
| CN114342959B (en) | Composition for simultaneously preventing and controlling cucumber aphids and cucumber bacterial angular leaf spot | |
| CN109984138A (en) | A kind of bactericidal composition | |
| CN109907051B (en) | Insecticidal composition containing fluazinam and propargite | |
| CN109122692B (en) | Insecticidal and acaricidal pesticide composition with synergistic effect | |
| CN115885998A (en) | Application of bactericidal composition containing mandipropamid and fluopicolide in preventing and treating phytophthora diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |